Department of Medicine 3 – Rheumatology and Immunology

JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO (2019) Adam S, Simon N, Steffen U, Harre N, Andes F, Mueller D, Culemann S, et al. Conference contribution COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY (2019) Kampylafka E, Englbrecht M, Tascilar K, Lerchen V, Linz C, Kleyer A, Simon D, et al. Conference contribution RESOLUTION OF VASCULAR INFLAMMATION IN PATIENTS WITH GIANT CELL ARTERITIS RECEIVING GLUCOCORTICOIDS, METHOTREXATE OR TOCILIZUMAB TREATMENT-DATA FROM THE ITALIAN/GERMAN RIGA STUDY (2019) Schonau V, Roth J, Tascilar K, Rech J, Schmidt D, Kuwert T, Crescentini F, et al. Conference contribution HOW THE GUT INFLUENCES THE IMMUNE SYSTEM (2019) Zaiss M Conference contribution ADVANCES IN THE DETECTION OF PATHOGENIC AUTOANTIBODIES IN SLE (2019) Munoz LE Conference contribution REGULATION OF AUTOANTIBODY ACTIVITY BY T CELL SUBSETS (2019) Krönke G Conference contribution POLYAUTOIMMUNITY AND MAJOR ORGAN INVOLVEMENT PREVALENCE IN SJOGREN'S SYNDROME: THYROID, LIVER, LUNG AND KIDNEY AS TARGETS. A SINGLE CENTER CROSS SECTIONAL STUDY (2019) Valor L, Schenker H, Hagen M, Knitza J, Rech J, Schett G Conference contribution Generation and Analysis of Human and Murine Osteoclasts (2019) Steffen U, Andes FT, Schett G Journal article Patients with Lupus Erythematosus often have increased Radiosensitivity (2019) Schuster B, Schenker H, Fietkau R, Distel L Conference contribution Scleroderma and Radiation Sensitivity (2019) Schenker H, Schuster B, Fietkau R, Distel L Conference contribution